(Q33340278)

English

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

object named as

H P Kalofonos

0 references

author name string

C Kosmas

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N Tsavaris

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Vadiaka

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N Stavroyianni

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Koutras

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

N Malamos

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Onyenadum

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Rokana

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Polyzos

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H P Kalofonos

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2902-2910

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: A multicenter phase II study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820011201%2992%3A11%3C2902%3A%3AAID-CNCR10103%3E3.0.CO%3B2-O

21 January 2018

Identifiers

10.1002/1097-0142(20011201)92:11<2902::AID-CNCR10103>3.0.CO;2-O

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33340278&oldid=1773390959"